bone
marrow
stromal
antigen
also
design
tetherin
type
ii
integr
membran
protein
contain
cytoplasm
region
follow
span
transmembran
domain
gpi
gene
function
innat
defens
system
viru
infect
describ
host
restrict
factor
capabl
imped
releas
sever
type
envelop
virus
includ
sendai
one
research
team
propos
inhibit
viru
releas
tether
nascent
virion
cell
surfac
via
transmembran
domain
gpi
envelop
virus
bud
directli
cell
surfac
small
number
envelop
virus
eg
herpesvirus
subject
restrict
even
though
final
envelop
entail
membran
tgn
andor
endosom
compart
egress
via
previou
studi
report
human
coronaviru
whose
assembl
bud
occur
intermedi
compart
whose
virion
releas
via
vesicl
also
subject
inhibit
result
electron
microscopi
analys
indic
presenc
virion
cell
surfac
membran
intracellular
vesicl
tend
cluster
suggest
tether
bud
virion
vesicl
membran
remain
cell
surfac
plasma
membran
describ
moder
restrict
releas
hepat
c
viru
whose
assembl
take
place
er
whose
releas
cell
via
secretori
pathway
occur
manner
similar
combin
data
support
assumpt
envelop
viru
bud
releas
occur
plasma
membran
intracellular
compart
subject
block
compon
innat
immun
respons
form
restrict
envelop
virion
releas
mani
virus
evolv
specif
antagonist
counteract
antivir
activ
vpu
env
simian
immunodefici
viru
siv
nef
env
ebola
sendai
viru
gp
kaposi
herpesviru
influenza
viru
neuraminidas
capabl
antagon
sinc
viral
factor
viral
envelop
glycoprotein
specul
spike
glycoprotein
may
possess
properti
counteract
block
viru
releas
work
built
part
earlier
find
anoth
research
team
accessori
protein
encod
inhibit
tether
also
found
spike
protein
capabl
downmodul
thu
mitig
restrict
particl
vlp
releas
suggest
envelop
virus
capabl
evolv
addit
factor
mammalian
express
vector
encod
n
e
provid
g
j
mutant
gift
klau
plasmid
kindli
provid
volker
serv
templat
gener
pcr
product
contain
nucldocapsid
code
sequenc
use
forward
primer
revers
primer
construct
express
vector
plasmid
contain
codon
optim
sequenc
synthes
mission
biotech
taiwan
serv
templat
use
forward
primer
forward
revers
primer
product
digest
bamhi
clai
clone
n
express
backbon
yield
express
vector
hela
stabl
hela
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
invitrogen
confluent
cell
trypsin
seed
onto
cm
dish
plate
hour
transfect
construct
cell
transfect
plasmid
dna
calcium
phosphat
precipit
method
chloroquin
ad
enhanc
transfect
effici
unless
otherwis
indic
plasmid
use
cotransfect
hela
transfect
plasmid
dna
mix
gencarri
epoch
biolab
ratio
transfect
procedur
perform
accord
manufactur
protocol
human
coronaviru
propag
hela
cell
describ
cultur
supernat
transfect
cell
collect
filter
centrifug
ml
sucros
tse
mm
ph
mm
nacl
mm
edta
plu
mm
phenylmethylsulfonyl
fluorid
pmsf
minut
pellet
suspend
ipb
mm
ph
mm
nacl
mm
edta
sd
sodium
deoxychol
triton
sodium
azid
plu
mm
pmsf
cell
rins
salin
pb
collect
ipb
plu
mm
pmsf
microcentrifug
minut
remov
unbroken
cell
debri
either
supernat
cell
sampl
mix
equal
volum
sampl
buffer
mm
ph
sd
glycerol
bromphenol
blue
boil
minut
sampl
incub
minut
sampl
resolv
electrophoresi
gel
electroblot
onto
nitrocellulos
membran
protein
immunodetect
use
rabbit
antiserum
ltk
biolaboratori
taiwan
monoclon
antibodi
n
detect
mous
monoclon
antibodi
probe
human
mous
antiserum
abcam
rabbit
vpu
detect
rabbit
secondari
antibodi
sheep
antimous
donkey
antirabbit
horseradish
hrp
conjug
antibodi
invitrogen
hela
cell
split
onto
coverslip
hour
transfect
hour
posttransfect
cell
wash
pb
either
directli
probe
antibodi
cell
membran
permeabil
cell
permeabl
aceton
minut
room
temperatur
fixat
formaldehyd
minut
sampl
incub
primari
antibodi
hour
secondari
antibodi
minut
incub
sampl
subject
three
wash
minut
dmemcalf
serum
probe
rabbit
detect
mous
monoclon
antirabbit
antimous
antibodi
serv
secondari
antibodi
cappel
icn
pharmaceut
aurora
oh
final
dmemcalf
serum
wash
coverslip
wash
three
time
pb
mount
glycerol
pb
view
imag
analyz
photograph
taken
use
invert
laser
zeiss
previou
report
determin
coexpress
either
n
unreport
result
suffici
vlp
product
test
abil
inhibit
coronaviru
vlp
releas
n
protein
coexpress
without
cell
express
vector
serv
control
sinc
releas
medium
n
releas
without
n
detect
medium
indic
vlp
form
n
accordingli
vlp
releas
level
measur
n
detect
medium
data
repeat
independ
experi
indic
coexpress
led
signific
decreas
vlp
yield
figur
inhibitori
effect
vlp
releas
occur
figur
also
use
hela
cell
constitut
express
assess
impact
endogen
vlp
yield
found
hela
cell
produc
vlp
higher
level
compar
normal
hela
cell
figur
suggest
vlp
releas
also
subject
restrict
associ
endogen
determin
whether
reduc
vlp
yield
result
vlp
tether
cell
membran
cell
treat
subtilisin
nonspecif
proteas
capabl
trigger
cell
virion
releas
via
result
indic
increas
vlp
quantiti
follow
subtilisin
treatment
figur
lane
vs
lane
confirm
trap
vlp
cell
surfac
combin
data
suggest
exogen
endogen
capabl
inhibit
vlp
releas
form
stabl
dimer
block
dimer
replac
cystein
alanin
ectodomain
turn
block
inhibit
releas
suggest
dimer
requir
virion
releas
test
whether
dimer
also
requir
restrict
coronaviru
vlp
releas
n
protein
coexpress
mutant
contain
alanin
substitut
result
indic
capabl
inhibit
vlp
product
figur
lane
vs
lane
suggest
dimer
requir
inhibit
coronaviru
vlp
releas
state
sever
viral
membran
glycoprotein
siv
env
well
ebola
sendai
viru
gp
protein
exert
counteract
effect
therefor
attempt
identifi
activ
associ
spike
protein
sinc
known
restrict
releas
absenc
vpu
perform
test
determin
whether
counteract
therefor
support
releas
shown
upper
panel
figur
lane
vs
lane
inhibitori
effect
virion
releas
decreas
presenc
either
vpu
step
reduc
express
figur
middl
panel
lane
suggest
capabl
promot
releas
viru
particl
cell
via
downregul
addit
experi
confirm
like
vpu
capabl
reduc
express
manner
figur
c
combin
data
suggest
may
counteract
restrict
vlp
releas
bind
vpu
move
toward
next
task
examin
whether
mediat
degrad
via
similar
pathway
transfect
treat
either
proteasom
inhibitor
ammonium
chlorid
lysosom
inhibitor
found
downregul
mediat
significantli
affect
proteasom
function
inhibit
notic
reduc
follow
lysosom
function
inhibit
figur
lane
consist
previou
report
observ
proteasom
lysosom
function
inhibit
result
markedli
reduc
downregul
figur
lane
suggest
downregul
mediat
larg
occur
via
lysosom
degrad
pathway
sinc
larg
local
cell
surfac
tether
virion
prevent
releas
test
whether
antagon
via
surfac
downregul
cell
cotransfect
express
vector
observ
coloc
perinuclear
area
signal
bare
detect
cell
surfac
instead
larg
local
perinuclear
area
regardless
whether
coexpress
figur
consist
previou
report
unlik
local
cell
surfac
well
perinuclear
area
exogen
predominantli
local
perinuclear
area
littl
distribut
cell
nevertheless
flow
cytometri
quantif
suggest
cell
surfac
express
notic
reduc
cell
follow
coexpress
figur
case
hela
cell
constitut
express
found
coloc
plasma
membran
figur
green
fluoresc
intens
hela
cell
surfac
decreas
slightli
follow
coexpress
suggest
capac
counteract
inhibit
virion
releas
due
part
cell
surfac
downmodul
capabl
inhibit
vlp
releas
figur
sinc
inhibit
releas
via
virion
tether
cell
surfac
well
document
use
vector
control
experi
shown
figur
coronaviru
vlp
similar
tether
cell
surfac
inhibit
vlp
releas
manner
similar
figur
manner
vpu
facilit
releas
via
downregul
figur
determin
vpu
downmodul
via
proteasom
lysosom
degrad
pathway
predomin
lysosom
pathway
mediat
figur
confoc
microscopi
observ
suggest
coloc
hela
cell
surfac
figur
like
bind
serv
target
lysosom
degrad
vpu
capabl
trap
intracellularli
prevent
recycl
back
plasma
whether
similarli
counteract
requir
investig
transmembran
protein
shown
counteract
tether
interf
addit
likelihood
restrict
virion
releas
mitig
possibl
number
envelop
virus
develop
supplementari
factor
addit
vpu
nef
capabl
overcom
restrict
viru
releas
certain
siv
capabl
antagon
influenza
protein
possess
capabl
research
suggest
influenza
andor
ebola
vlp
releas
virion
releas
inhibit
due
biosafeti
requir
current
unabl
perform
test
determin
whether
capabl
overcom
restrict
virion
releas
